Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $711.08 billion, total revenue of $168.76 billion and a weighted average PE ratio of 40.65.
Market Cap
711.08B
Revenue
168.76B
Profits
17.49B
PE Ratio
40.65
Profit Margin
10.37%
Dividend Yield
0.23%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 182.91B | 4.87% | 1,548,068 | 45.20B |
| 2 | DHR | Danaher Corporation | 133.68B | 5.53% | 5,646,963 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.32B | 1.45% | 643,401 | 4.45B |
| 4 | NTRA | Natera, Inc. | 37.23B | 10.74% | 2,941,677 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 37.18B | 3.92% | 1,633,014 | 7.23B |
| 6 | WAT | Waters Corporation | 36.25B | 3.35% | 928,263 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 30.98B | 8.37% | 1,862,397 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 26.49B | 6.16% | 2,132,802 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 24.31B | 4.02% | 294,792 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.48B | 3.01% | 1,135,807 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.74B | 2.55% | 481,499 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 18.16B | 4.69% | 3,856,958 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 14.65B | 8.30% | 503,481 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 12.11B | 10.86% | 2,406,383 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 11.78B | 5.74% | 1,680,645 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 9.73B | 8.31% | 936,779 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.01B | 4.11% | 2,545,636 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 5.69B | 7.47% | 2,602,592 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 4.96B | 3.32% | 1,161,759 | 354.54M |
| 20 | SHC | Sotera Health Company | 4.76B | 5.37% | 4,678,188 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.57B | 3.49% | 902,446 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.53B | 5.52% | 1,304,270 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.10B | 12.25% | 5,523,503 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.77B | 5.68% | 629,529 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.89B | 9.40% | 1,451,876 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.68B | 12.47% | 6,124,410 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.40B | 8.00% | 1,369,023 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.19B | 12.92% | 5,757,915 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.13B | 2.05% | 2,370,994 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 670.90M | 3.46% | 299,388 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 543.30M | 5.23% | 266,245 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 493.02M | 12.74% | 1,718,148 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 188.73M | -2.56% | 108,605 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 173.72M | 0.19% | 313,436 | 1.95M |
| 35 | XGN | Exagen Inc. | 109.20M | 3.79% | 122,551 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 89.85M | 12.70% | 62,337 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 41.04M | -1.03% | 26,279 | 25.83M |
| 38 | MDXH | MDxHealth SA | 24.13M | -8.76% | 653,784 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 21.55M | -1.34% | 1,852,095 | 537.08K |
| 40 | MBAI | Check-Cap Ltd. | 9.40M | -5.15% | 84,166 | - |
| 41 | XWEL | XWELL, Inc. | 9.29M | 0.92% | 33,094 | 28.83M |
| 42 | ADVB | Advanced Biomed Inc. | 8.00M | -5.29% | 7,885 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 7.96M | 18.08% | 58,076 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 3.85M | 0.87% | 358,240 | 5.66M |
| 45 | ISPC | iSpecimen Inc. | 3.85M | 5.51% | 99,940 | 1.03M |